| P2093 | author name string | D S Ross | |
| P2860 | cites work | Does prophylactic thyroxine treatment after operation for non-toxic goitre influence thyroid size? | Q34069340 |
| | The Role of Thyroid Hormone Deiodination in the Regulation of Hypothalamo-Pituitary Function | Q34257622 |
| | Are biochemical tests of thyroid function of any value in monitoring patients receiving thyroxine replacement? | Q34288974 |
| | Raised plasma glutathione S-transferase values in hyperthyroidism and in hypothyroid patients receiving thyroxine replacement: evidence for hepatic damage. | Q34486170 |
| | Total and free thyroid hormone concentrations in patients receiving maintenance replacement treatment with thyroxine. | Q34556047 |
| | Spectrum of Pituitary Alteration with Mild and Severe Thyroid Impairment* † | Q39660625 |
| | Thyroidal and peripheral production of thyroid hormones. Review of recent findings and their clinical implications | Q39868994 |
| | Compromise therapy in the patient with angina pectoris and hypothyroidism. A clinical assessment | Q41479439 |
| | Triiodothyronine rapidly decreases transcription of the thyrotropin subunit genes in thyrotropic tumor explants | Q42507531 |
| | Factors affecting suppression of endogenous thyrotropin secretion by thyroxine treatment: retrospective analysis in athyreotic and goitrous patients | Q42526663 |
| | Relevance of increased serum thyroxine concentrations associated with normal serum triiodothyronine values in hypothyroid patients receiving thyroxine: a case for "tissue thyrotoxicosis". | Q43010849 |
| | L-thyroxine dosage: a reevaluation of therapy with contemporary preparations | Q45050144 |
| | Changes in serum triiodothyronine, thyroxine, and thyrotropin during treatment with thyroxine in severe primary hypothyroidism | Q67774227 |
| | Suppressive therapy with levothyroxine for solitary thyroid nodules. A double-blind controlled clinical study | Q68156481 |
| | Bone loss in hypothyroidism with hormone replacement. A histomorphometric study | Q68858125 |
| | Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine | Q69106089 |
| | Reevaluation of L-thyroxine dosage | Q69634733 |
| | Relationship between pituitary and other target organ responsiveness in hypothyroid patients receiving thyroxine replacement | Q69694256 |
| | Replacement dosage of L-thyroxine in hypothyroidism. A re-evaluation | Q69733953 |
| | Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans | Q69761584 |
| | Elevated serum thyroxine concentration in patients receiving "replacement" doses of levothyroxine | Q70404513 |
| | The effect of minor increments in plasma thyroxine on heart rate and urinary sodium excretion | Q70440721 |
| | Oral thyroxine: variation in biologic action and tablet content | Q70812251 |
| | 'Chemical hyperthyroidism': the significance of elevated serum thyroxine levels in L-thyroxine treated individuals | Q93594533 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1223-1229 | |
| P577 | publication date | 1988-12-01 | |
| P1433 | published in | Mayo Clin Proc | Q6538184 |
| P1476 | title | Subclinical hyperthyroidism: possible danger of overzealous thyroxine replacement therapy | |
| P478 | volume | 63 | |